Next |
home / stock / apri / apri message board
Subject | By | Source | When |
---|---|---|---|
one more thing : my other message is | smul | investorshub | 08/31/2022 8:28:07 PM |
invest in seel for another 9 months, be | smul | investorshub | 08/31/2022 8:22:18 PM |
Seelos Therapeutics Receives a Research and Development Grant | harr449 | investorshub | 08/24/2022 4:32:37 PM |
Yep. Nice to see it finally back | Invest83838 | investorshub | 08/18/2022 11:45:21 PM |
still needs to go up for 150%, but | smul | investorshub | 08/18/2022 6:50:45 PM |
This isn't a good stock as to day | irv12 | investorshub | 07/15/2022 6:58:41 PM |
Disappointed though with the action after market open | novicetrader | investorshub | 07/12/2022 1:25:04 AM |
good call ... over a dollar right now. | irv12 | investorshub | 07/11/2022 2:03:39 PM |
With recent insider buys to top that too. | novicetrader | investorshub | 07/07/2022 2:59:21 PM |
13%, 14%, and 20%, gains ... three straight | irv12 | investorshub | 07/07/2022 1:29:02 PM |
Seems fair. Rod hates this company so thats | food4thought | investorshub | 05/20/2022 5:32:56 PM |
hey, i'm not Rod and certainly not God, | smul | investorshub | 05/20/2022 4:22:26 PM |
$SEEL https://seelostherapeutics.com/investors-and-media/ | harr449 | investorshub | 11/24/2021 2:12:40 PM |
https://ih.advfn.com/stock-market/NASDAQ/seelos-therapeutics-$SEEL/stock-news/866 | TheFinalCD | investorshub | 11/24/2021 2:00:36 PM |
Undervalued | trickledownfacists | investorshub | 11/11/2021 4:28:12 PM |
Pipeline updated October 2021: | harr449 | investorshub | 11/08/2021 9:53:57 PM |
Seelos Therapeutics Announces FDA Acceptance of Investigational New | harr449 | investorshub | 11/08/2021 2:46:38 PM |
6,561,278 shares traded today. | mik1234 | investorshub | 10/23/2021 2:49:25 AM |
Yup | trickledownfacists | investorshub | 10/07/2021 5:00:43 PM |
Sharp dip in first 30 minutes, down 6%. 2.20. | harr449 | investorshub | 10/06/2021 2:50:33 PM |
News, Short Squeeze, Breakout and More Instantly...
Apricus Biosciences Inc. Company Name:
APRI Stock Symbol:
NASDAQ Market:
Apricus Biosciences Inc. Website:
Seeking Shareholder Approval for Proposed Merger with Seelos Therapeutics, Inc. SAN DIEGO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, reminds shareholders to vote by...
Company Merger with Seelos Therapeutics, Inc. Expected to Close in Fourth Quarter 2018 Apricus Shareholders Expected to Own ~15% of Estimated $94 Million Combined Company Valuation at Closing SAN DIEGO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a bioph...